Tanvex BioPharma Market Cap

Tanvex BioPharma has a market cap or net worth of 11.37 billion as of January 17, 2025. Its market cap has increased by 16.51% in one year.

Market Cap

11.37B

Enterprise Value

12.28B

Revenue

40.96M

Ranking

n/a

PE Ratio

n/a

Stock Price

68.50

Market Cap Chart

Since August 13, 2015, Tanvex BioPharma's market cap has decreased from 16.77B to 11.37B, a decrease of -32.20%. That is a compound annual growth rate of -4.03%.

Market Cap History

Date	Market Cap	% Change
Jan 20, 2025	11.24B	5.06%
Dec 31, 2024	10.70B	22.75%
Dec 29, 2023	8.71B	-29.59%
Dec 30, 2022	12.38B	-39.56%
Dec 30, 2021	20.48B	106.96%
Dec 31, 2020	9.89B	-9.41%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	235.68B
Caliway Biopharmaceuticals	98.05B
Bora Pharmaceuticals Co., LTD.	80.81B
Lotus Pharmaceutical	69.14B
Lumosa Therapeutics	40.11B
Oneness Biotech	37.34B
Polaris Group	32.38B
Center Laboratories	29.18B

Market Cap Rankings